1. Achermann J, Jameson L. Fertility and infertility: genetic contributions from the hypothalamo-pituitary-gonadal axis. Molecular Endocrinology 1999; 13:812-8.
2. Dattani MT et al. Mutations in the homeobox gene HESX1/Hesx1 associated with septo-optic dysplasia in human and mouse. Nature Genetics 1998;19:125-33.
3. Aarskog D, Eiken HG, Bjerknes R, Myking OL. Pituitary dwarfism in the R271W Pit-1 gene mutation. European Journal of Pediatrics 1997;156:829-34.
4. Radovick S et al. A mutation of the POU domain of pit-1 is responsible for familial combined pituitary hormone deficiency. Science 1992; 257:1115-8.
5. Parks JS, Brown MR, Hurley DL, Phelps CJ, Wajnrajch MP. Heritable Disorders of pituitary development. J Clin Endocrinol Metab 1999; 84: 4362-4370.
6. Fofanova O, Takamura N, Kinoshita E et al. Compound heterozygous deletion of the PROP-1 gene in children with combined pituitary hormone deficiency. J Clin Endocrinol Metab 1998; 83:2601-2604.
7. Deladoey J, Fluck C, Buyukgebiz A, et al. "Hot spot" in the PROP-1 gene responsible for combined pituitary hormone deficiency. J Clin Endocrinol Metab 1999; 84:1645-1650.
8. Bick D, Franco B, Sherins RJ, Heye B, Pike L, Crawford J et al. Brief report: intragenic deletion of the KALIG-1 gene in Kallman's syndrome. N Engl J Med 1992; 326: 1752.
9. Buris TP, Guo W, McCabe ER. The gene responsible for adrenal hypoplasia congenita, DAX-1, encodes a nuclear hormone receptor that defines a new class within the superfamily. Recent Prog Horm Res 1996; 51:241.
10. Kovacs, K. Scheithauer, B. W., Horvath, G., Lloyd, R. V: The World Health Organization classification of adenohypophysial neoplasms. Cancer 1996; 78: 502 - 10.
11. Katznelson, L., Alexander, J. M., Klibanski, A: Clinically non-functioning pituitary adenomas. J Clin Endocrinol Metab 1993; 76: 1089 - 94.
12. DeVile CJ, Grant DB, Hayward RD, Stanhope R. Growth and endocrine sequelae of craniopharyngioma. Archives of Disease in Childhood 1996; 75:108-14.
13. Adamson, T. E., Wiestler, O. D., Kleihues, P., Yasargil, M. G. Correlation of clinical and pathological features in surgically treated craniopharyngiomas. J. Neurosurg 1990; 73: 12 - 17.
14. Ross DA, Norma D, Wilson CB. Radiologic characteristics and results of surgical management of Rathke's cysts in 43 patients. Neurosugery 1992; 30;173-8.
15. Adams CBT. The management of pituitary tumours and postoperative visual deterioration. Acta Neurochirurgica 1988; 94: 103-16.
16. Takeuchi J, Handa H, Nagata. Suprasellar germinoma. J Neurosurg 1978; 49:41-48.
17. Bloom HJG, Bagshawe KD, Newlands ES, Begent RH. Primary intracranial tumours. Clinics in Oncology 1983; 2:233-252.
18. Ho DM, Liu HC. Primary intracranial germ cell tumour. Pathologic study of 51 patients. Cancer 1992; 70:1577-1584.
19. Janmohamed S, Grossman AB, Metcalfe K, Lowe DG, Wood DF, Chew SL, Monson JP, Besser GM, Plowman PN. Suprasellar germ cell tumours: specific problems and the evolution of optimal management with a combined chemoradiotherapy regimen. Clin Endocrinol 2002;57(4):487-500.
20. Max MB, Deck MD, Rottenberg DA. Pituitary metastasis: incidence in cancer patients and clinical differentiation from pituitary adenoma. Neurology 1981;31:998-1002.
21. Bills DC, Meyer FB, Laws ER et al. A retrospective analysis of pituitary apoplexy. Neurosurgery 1993; 33:602-609.
22. Wakai S, Fukushina T, Teramoto A, Sano K. Pituitary apoplexy: its incidence and clinical significance. J Neurosurg 1981; 55:187-193.
23. Radeva H, Harpal S, Schoebel J, Byne J, Esiri M, Adams CBT, Wass JAH. Classical pituitary apoplexy: clinical features, management and outcome. Clin Endocrinol 1999;51:181-188.
24. Barkan AL. Pituitary atrophy in patients with Sheehan's syndrome. Am J Medical Science 1989;298:38-40.
25. Post K, McCormick PC, Bell JA. Differential diagnosis of pituitary tumours. Endocrinology Metab Clin North Am 1987;16:609-45.
26. Jenkins PJ et Lymphocytic hypophysitis: unusual features of a rare condition. Clin Endocrinol 1995;42:529-34.
27. Cheung CC, Ezzat S, Smyth HS, Asa SL. The spectrum and significance of primary hypophysitis. J Clin Endocrinol Metabol 2001;86:1048-1053.
28. Asa SL, Bilbao JM, Kovacs K, Josse RG, Kreines K. Lymphocytic hypophysitis of pregnancy resulting in hypopituitarisism: a distinct clinicopathological entity. Ann Intern Med 1981;95:166-171.
29. Thodou E, Asa SL, Kontogeorgos G, etal. Clinical case seminar: Lymphocytic hypophysitis: Clinicopathological findings. J Clin Endocrinol Metab 1995;80:2302-11.
30. Ji JD, Lee SY, Choi SJ, et al Lymphocytic hypophysitis in a patient with systemic lupus erythematosus. Clin Exp Rheumatol 2000;18:78-80.
31. Jenkins PJ. Inflammatory lesions - lymphocytic hypophysitis, sarcoid, histocytosis, TB, Wegener's granulomatosis. In: Oxford Textbook of Endocrinology and Diabetes (Eds Wass JAH, Shalet SM, Oxford University Press) 2002 ;236-242.
32. Chapelon C, Ziza JM, Piette JC, Levy Y, Raguin G, Wechsler B, et al. Neurosarcoidosis: signs, course and treatment in 35 confirmed cases. Medicine (Baltimore) 1990;69:261-76.
33. Oksanen V. Neurosarcoidosis: clinical presentations and course in 50 patients. Acta Neurol Scand. 1986;73:283-90.
34. Stern BJ, Krumholz A, Johns C et al. Sarcoidosis and its neurological manifestations. Arch Neurol (Chic) 1985;42:909-17.
35. Malarkey WE, Kataria YP. Letter: sarcoidosis and hyperprolactinemia. Ann Int Med 1974;81:116.
36. Bell NH. Endocrine complications of sarcoidosis. Endocrinol Metab Clin North Am 1991;20:645-54.
37. Willman LC, Busque L, Griffith B, etal. Langerhans'-cell histocytosis (histocytosis X)- a clonal proliferative disease. N Engl J Med 1994;331:154-160.
38. Kaltsas TB, Powles TB, Evanson J, Plowman PN, Drinkwater JE, Jenkins PJ, Monson JP, Besser GM, Grossman AB. Hypothalamo-pituitary abnormalities in adult patients with Langerhans Cell Histiocytosis: clinical, endocrinological, and radiological features and response to treatment. J Clin Endocrinol Metab 2000;85:1370-1376.
39. Basaria S, Ayala AR, Guerin C et al. A rare pituitary lesion. J Endcrinol Invest 2000;23:189-92.
40. Ferreiro J, Vinters HV. Pathology of the pituitary gland in patients with the acquired immune deficiency syndrome (AIDS). Pathology 1988;20:211-5.
41. Milligan SA, Katz MS, Carven PC et al. Toxoplasmosis presenting as panhypopituitarism in a patient with the acquired immune deficiency syndrome. Am J Med 1984;77:760-3.
42. Littley MD, Shalet SM, Berdwell CG, Ahmed SR, Applegate G, Sutton ML. Hypopituitarism following external radiatherapy for pituitary tumours in adults. Q J Med 1988;262:145-60.
43. De Boer H, Blok GJ, Van de Veen EA. Clinical aspects of growth hormone deficiency in adults. Endocrine Reviews 1995;16:63-86.
44. Carroll PV, Christ ER et al. Growth hormone deficiency in adulthood and the effects of growth hormone replacement: A review. J Clin Endocrinol Metab 1998;83:382-395.
45. Christ E, Carroll PV, Sonksen PH. Adult growth hormone deficiency. In: Oxford Textbook of Endocrinology and Diabetes (Eds Wass JAH, Shalet SM; Oxford:University Press) 2002;151-160.
46. Bulow B, Hagmar L, Eskilsson J, Erfurth EM. Hypopituitary Females have a high incidence of cardiovascular morbidity and an increased prevalence of cardiovascular risk factors. J Clin Endocrinol Metab 2000;85(2):574-584.
47. Rosen T, Bengtsson BA. Increased fracture frequency in adult patients with hypopituitarism and growth hormone deficiency. Eur J Endocrinol 1997;137:240-245.
48. Maghnie M, Cosi G, Eugenio G, Manca-Britti ML, Cohen A, Zecca S et al. Central diabetes insipidus in Children and Young adults. N Eng J Med 2000;343:998-1007.
49. Trainer PJ, Besser GM. The Bart's Endocrine Protocols. Churchill Livingstone International, Edinburgh. 1995.
50. Hurel SJ, Thompson CJ, Watson MJ, Baylis PH, Kendall-Taylor P. The short synacthen and insulin stress tests in insulin stress tests in the assessment of the hypothalamic-pituitary-adrenal axis. Clin Endocrinol 1996;44:141-6.
51. Parvord SR et al. A retrospective audit of the combined pituitary function test, using the insulin stress test, TRH and GnRH in a district laboratory. Clin Endocrinol 1992;26:135-9.
52. Jones SL, Trainer PJ, Perry L, Wass JA, Besser GM, Grossman A. An audit of the insulin tolerance test in adult subjects in an acute investigation unit over one year. Clin Endocrinol 1995;42:101-2.
53. Littley MD, Gibson S, White A, Shalet SM. Comparison of the ACTH and cortisol responses to provocative testing with glucagon and insulin induced hypoglycaemia in normal subjects. Clin Endocrinol 1989;31:527-33.
54. Hoffman DM, O'Sullivan AJ, Baxter RC, Ho KY. Diagnosis of growth hormone deficiency in adults. Lancet 1994;343:1064-8.
55. Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statements of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency. J Clin Endocrinol Metab 1998;83:379-81.
56. Ghigo E, Bellone J, Aimaretti J, Bellone S, Loche S, Cappa M, Bartolotta E, Dammacco F, Capanni F. Reliability of provocative tests to assess GH secretory status. Study in 472 normally growing children. J Clin Endocrinol Metab 1996;81:3323-3327.
57. Valetto MR, Bellone J, BaffoniC, Savio P, Aimaretti G, Gianotti L, Arvat E, Camanni F, Ghigo E. Reproducibility of the growth hormone response to stimulation with growth hormone-releasing hormone plus arginine during lifespan. Eur J Endocrinol 1996;135:568-572.
58. Maghnie M, Cavigioli F, Tinelli C, Autelli M, Arcico M, Aimaretti G, Ghigo E. GHRH plus Arginine in the diagnosis of acquired GH deficiency of childhood onset. 2002;87:2740-2744.
59. Groves RW, Toms GC, Houghton BJ, Monson JP. Corticosteroid replacement therapy:twice or thrice daily? J Roy Soc Med 1988;81:514-516.
60. Howlett TA. An assessment of optimal hydrocortisone replacement therapy. Clin Endocrinol 1997;46:263-268.
61. Peacey SR, Guo C, Robinson AM, Price A, Giles MA, Eastell R, Weetman AP. Glucocorticoid replacement therapy: are patients overtreated and does it matter? Clin Endocrinol 1997;46:255-261.
62. Swords FM, Drake WM, Carroll PV, Monson JP. Hormonal Therapy for Hypopituitarism. In: Encyclopaedia of Endocrine Disease (Ed L Martini), Vol 2, 662-671 (2004).
63. Franklyn JA. Diagnosis and treatment of thyrotrophin deficiency. In: The diagnosis and treatment of pituitary insufficiency. (Ed Lamberts SWJ; Bristol: BioScientifica) 1997:99-111.
64. Bhasin S, Storer TW, Berman N, Yarasheski K, Clevenger B etal. Testosterone replacement increases fat-free mass and muscle size in hypogonadal men. J Clin Endocrinol Metab 1997;82(2):407-413.
65. Handelsman DJ, Conway AJ, Boylan LM. Pharmacokinetics and pharmacodynamics of testosterone pellets in man. J Clin Endocrinol Metab 1990;71:216-222.
66. Korbonits M, Slawik M, Cullen D, Ross RJ, Stalla G, Schneider H, Reincke M, Bouloux PM, Grossman AB. A comparison of a novel testosterone bioadhesive buccal system, striant, with a testosterone adhesive patch in hypogonadal males. J Clin Endocrinol Metab (2004), 89, 2039-2043.
67. Odeh M, Oliven A. Coma and seizures due to severe hyponatraemia and water intoxication in an adult with intranasal desmospressin therapy for noctural enuresis. J Clin Pharm 2001;41:582-584.